User:Olivier Laprevote/Sandbox 1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
==Proto-oncogene vav==
+
=Proto-oncogene vav=
<StructureSection load='3ky9' size='340' side='right' caption='Caption for this structure' scene='75/751211/Monomerous_vav/1'>
<StructureSection load='3ky9' size='340' side='right' caption='Caption for this structure' scene='75/751211/Monomerous_vav/1'>
Line 33: Line 33:
Src-homology domains SH3-SH2-SH3 (residues 617 - 842): the activators of Vav like Syk or ZP-70 fix on its SH2 region <ref>PMID: 9850860</ref>. Potential inhibitors of Vav also dock on its SH3-SH2-SH3 region, such as SHP which would remove the phosphate on Y174 <ref>PMID: 8632004</ref> or Cbl-b <ref>PMID: 9399639</ref>. It has also been proven that the C-ter SH3 was involved in the auto-inhibition of Vav. <ref>PMID: 24736456  </ref>
Src-homology domains SH3-SH2-SH3 (residues 617 - 842): the activators of Vav like Syk or ZP-70 fix on its SH2 region <ref>PMID: 9850860</ref>. Potential inhibitors of Vav also dock on its SH3-SH2-SH3 region, such as SHP which would remove the phosphate on Y174 <ref>PMID: 8632004</ref> or Cbl-b <ref>PMID: 9399639</ref>. It has also been proven that the C-ter SH3 was involved in the auto-inhibition of Vav. <ref>PMID: 24736456  </ref>
-
== Auto-inhibition and activation ==
+
=== Auto-inhibition ===
When Tyr-174 on the Ac domain is not phosphorylated, Vav1 is auto-inhibited. It has long been thought that only the CH and Ac domain interactions with the DH, PH and C1/ZN domains played a role in auto-inhibition. Indeed, <scene name='75/751211/Ch_ph/2'>CH domain residues 66-68 interact with the PH domain residues 406-408</scene>, forming beta-sheet like hydrogen bonds. There is also a <scene name='75/751211/Ph_ac/1'>close interaction between the PH and Ac domains</scene>interaction between the PH and Ac domains, some oppositely charged residues facing each other like Asp-150 on Ac and Lys-487 on PH.
When Tyr-174 on the Ac domain is not phosphorylated, Vav1 is auto-inhibited. It has long been thought that only the CH and Ac domain interactions with the DH, PH and C1/ZN domains played a role in auto-inhibition. Indeed, <scene name='75/751211/Ch_ph/2'>CH domain residues 66-68 interact with the PH domain residues 406-408</scene>, forming beta-sheet like hydrogen bonds. There is also a <scene name='75/751211/Ph_ac/1'>close interaction between the PH and Ac domains</scene>interaction between the PH and Ac domains, some oppositely charged residues facing each other like Asp-150 on Ac and Lys-487 on PH.
Line 39: Line 39:
Tyr-541 and Tyr 544 on C1 and Tyr-836 on the C-terminal SH3 domains have also to get phosphorylated in order to activate Vav1, the SH3 domain also binding on the DH (residues 371 – 388) if this tyrosine wasn’t phosphorylated. <ref>PMID:24736456 </ref>
Tyr-541 and Tyr 544 on C1 and Tyr-836 on the C-terminal SH3 domains have also to get phosphorylated in order to activate Vav1, the SH3 domain also binding on the DH (residues 371 – 388) if this tyrosine wasn’t phosphorylated. <ref>PMID:24736456 </ref>
 +
 +
=== Activation ===
The phosphorylation of Tyr-174 in vivo happens within seconds after a kinase has bound to Vav1. It induces the deformation of the inhibitory helix, thus et separates itself of the active site of the DH domain. The phosphorylation of Tyr-160 and -142 makes Tyr-174 more accessible as it lessen the interactions between the CH and Acidic domains. <ref>PMID: 20141838 </ref>
The phosphorylation of Tyr-174 in vivo happens within seconds after a kinase has bound to Vav1. It induces the deformation of the inhibitory helix, thus et separates itself of the active site of the DH domain. The phosphorylation of Tyr-160 and -142 makes Tyr-174 more accessible as it lessen the interactions between the CH and Acidic domains. <ref>PMID: 20141838 </ref>

Revision as of 22:30, 27 January 2017

Proto-oncogene vav

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. http://mcb.asm.org/content/20/5/1461.full
  2. http://www.proteinatlas.org/ENSG00000141968-VAV1/tissue
  3. Fujikawa K, Miletic AV, Alt FW, Faccio R, Brown T, Hoog J, Fredericks J, Nishi S, Mildiner S, Moores SL, Brugge J, Rosen FS, Swat W. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J Exp Med. 2003 Nov 17;198(10):1595-608. PMID:14623913 doi:http://dx.doi.org/10.1084/jem.20030874
  4. Quaranta MG, Mattioli B, Spadaro F, Straface E, Giordani L, Ramoni C, Malorni W, Viora M. HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells. FASEB J. 2003 Nov;17(14):2025-36. PMID:14597672 doi:http://dx.doi.org/10.1096/fj.03-0272com
  5. http://smart.embl.de/smart/show_motifs.pl?GENOMIC=1&DO_PFAM=DO_PFAM&INCLUDE_SIGNALP=INCLUDE_SIGNALP&ID=9606.ENSP00000472929
  6. Yu B, Martins IR, Li P, Amarasinghe GK, Umetani J, Fernandez-Zapico ME, Billadeau DD, Machius M, Tomchick DR, Rosen MK. Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1. Cell. 2010 Jan 22;140(2):246-56. PMID:20141838 doi:10.1016/j.cell.2009.12.033
  7. Llorca O, Arias-Palomo E, Zugaza JL, Bustelo XR. Global conformational rearrangements during the activation of the GDP/GTP exchange factor Vav3. EMBO J. 2005 Apr 6;24(7):1330-40. Epub 2005 Mar 10. PMID:15775967 doi:http://dx.doi.org/10.1038/sj.emboj.7600617
  8. Yu B, Martins IR, Li P, Amarasinghe GK, Umetani J, Fernandez-Zapico ME, Billadeau DD, Machius M, Tomchick DR, Rosen MK. Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1. Cell. 2010 Jan 22;140(2):246-56. PMID:20141838 doi:10.1016/j.cell.2009.12.033
  9. http://pfam.xfam.org/family/PF00621
  10. Movilla N, Bustelo XR. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol Cell Biol. 1999 Nov;19(11):7870-85. PMID:10523675
  11. Han J, Luby-Phelps K, Das B, Shu X, Xia Y, Mosteller RD, Krishna UM, Falck JR, White MA, Broek D. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science. 1998 Jan 23;279(5350):558-60. PMID:9438848
  12. Chu DH, Morita CT, Weiss A. The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol Rev. 1998 Oct;165:167-80. PMID:9850860
  13. Kon-Kozlowski M, Pani G, Pawson T, Siminovitch KA. The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells. J Biol Chem. 1996 Feb 16;271(7):3856-62. PMID:8632004
  14. Bustelo XR, Crespo P, Lopez-Barahona M, Gutkind JS, Barbacid M. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation. Oncogene. 1997 Nov 20;15(21):2511-20. PMID:9399639
  15. PMID: 24736456 
  16. PMID: 20141838
  17. Barreira M, Fabbiano S, Couceiro JR, Torreira E, Martinez-Torrecuadrada JL, Montoya G, Llorca O, Bustelo XR. The C-terminal SH3 domain contributes to the intramolecular inhibition of Vav family proteins. Sci Signal. 2014 Apr 15;7(321):ra35. doi: 10.1126/scisignal.2004993. PMID:24736456 doi:http://dx.doi.org/10.1126/scisignal.2004993
  18. PMID: 20141838
  19. http://www.ebi.ac.uk/intact/interaction/EBI-7944187;jsessionid=8AD6943D454A170511925DF549C751E4

Proteopedia Page Contributors and Editors (what is this?)

Olivier Laprevote

Personal tools